Not applicableStudy completedNCT02747017What this trial is testingObservational Study of C. Diff in Post-Transplant PatientsWho this might be right forClostridium Difficile University of Minnesota 132
Large-scale testing (Phase 3)Study completedNCT05831189What this trial is testingA Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile InfectionWho this might be right forClostridium Difficile Infection Recurrence Ferring Pharmaceuticals 41
Not applicableStudy completedNCT00446355What this trial is testingClinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC GenotypesWho this might be right forClostridium Infections University of Pittsburgh 1,000
Large-scale testing (Phase 3)WithdrawnNCT07221708What this trial is testingPrimary Prophylaxis of Clostridioides Difficile Infection With Oral VancomycinWho this might be right forClostridioides DifficileVancomycin Resistance Enterococcus Faecium University of Maryland, Baltimore
Early research (Phase 1)Study completedNCT01551004What this trial is testingPhase I Trial of a Single Dose of CRS3123Who this might be right forClostridium Difficile Colitis National Institute of Allergy and Infectious Diseases (NIAID) 40
Large-scale testing (Phase 3)Ended earlyNCT00177775What this trial is testingWhey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-DiarrheaWho this might be right forPositive C-Diff Culture University of Pittsburgh 60
Not applicableEnded earlyNCT02730325What this trial is testingTo Evaluate the Impact of SBI on C. Difficile in Hospitalized UC PatientsWho this might be right forClostridium Difficile Northwestern University 10
Post-approval studies (Phase 4)Ended earlyNCT00177970What this trial is testingIVIG Versus Placebo for the Treatment of Patients With Severe C-DiffWho this might be right forClostridium Difficile-associated Diarrhea (CDAD) University of Pittsburgh 14
Testing effectiveness (Phase 2)Looking for participantsNCT07285213What this trial is testingPrevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal AntibodyWho this might be right forClostridioides Difficile Infection AstraZeneca 230
Not applicableStudy completedNCT01066221What this trial is testingComparative Study of Three Different Testing Mechanisms for Clostridium DifficileWho this might be right forClostridium Difficile Hamilton Health Sciences Corporation 470
Early research (Phase 1)Study completedNCT04893239What this trial is testingExploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With OstomiesWho this might be right forC. Diff. Infections Lumen Bioscience, Inc. 12
Not applicableStudy completedNCT03117582What this trial is testingFecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to AntibioticsWho this might be right forClostridium Difficile University of North Carolina, Chapel Hill 34
Testing effectiveness (Phase 2)Study completedNCT03497806What this trial is testingOpen-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile InfectionWho this might be right forClostridium Difficile InfectionRecurrent Clostridium Difficile InfectionC. Diff+8 more Finch Research and Development LLC. 132
Testing effectiveness (Phase 2)Study completedNCT02299570What this trial is testingMicrobiota Restoration Therapy for Recurrent Clostridium Difficile InfectionWho this might be right forEnterocolitis Clostridium Difficile Recurrent Rebiotix Inc. 150
Early research (Phase 1)Study completedNCT02830542What this trial is testingSER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent RecurrenceWho this might be right forClostridium Difficile Infection Seres Therapeutics, Inc. 96
Large-scale testing (Phase 3)Ended earlyNCT05153499What this trial is testingA Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)Who this might be right forRecurrent C. Difficile Infection Finch Research and Development LLC. 19
Testing effectiveness (Phase 2)Study completedNCT03462459What this trial is testingEfficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile InfectionWho this might be right forRecurrent Clostridium Difficile InfectionClostridium Difficile InfectionCDI+3 more University of Wisconsin, Madison 79
Testing effectiveness (Phase 2)Active Not RecruitingNCT05805826What this trial is testingTo Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy AdultsWho this might be right forClostridoides Difficile Associated Disease Pfizer 936
Post-approval studies (Phase 4)Ended earlyNCT04626947What this trial is testingPrevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).Who this might be right forInflammatory Bowel DiseasesUlcerative ColitisCrohn Disease+1 more David Binion, MD 19
Not applicableLooking for participantsNCT07250724What this trial is testingC. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.Who this might be right forClostridioides Difficile Infection Recurrence Bactolife A/S 60